Whitepaper: Two Poles. One Spectrum.

European Life Science Real Estate – An Institutional Perspective

Life Science Real Estate provides the physical infrastructure for research, testing, production and distribution. Yet it encompasses a broad spectrum of investment characteristics, requiring a differentiated assessment.

Our whitepaper explores this spectrum, with a particular focus on laboratory properties: from long-let shell-and-core buildings to fully operated laboratory platforms. It examines how operating models, tenant commitments, building specifications and cluster quality shape risk, return and portfolio suitability.

The whitepaper addresses five central questions:

• How do different laboratory operating models affect investment risk?

• Who finances and manages fit-out, scientific infrastructure and operations?

• What supports long-term tenant commitment and resilient property income?

• Why is cluster quality an integral part of the investment case?

• How can institutional real estate capital help finance Europe’s life science infrastructure?
  

Published by HELIX alpha, the paper offers a framework for institutional investors and a shared basis for dialogue across the real estate, life science and capital markets communities.

Get the whitepaper: To receive a complimentary copy in English or German, please email info@helix-alpha.com, stating your name, company and role, together with your preferred language.